54 min listen
AUA2024: Contemporary Pharmacotherapy for OAB 2024
FromAUAUniversity
ratings:
Length:
126 minutes
Released:
Jun 12, 2024
Format:
Podcast episode
Description
AUA2024: Contemporary Pharmacotherapy for OAB 2024: Monotherapy and Combined Pharmacotherapy to Optimize Treatment
CME Available: https://auau.auanet.org/node/41048
At the conclusion of this activity, participants will be able to:
1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB)
2. Review the principles of physiology and pharmacotherapy for currently available agents including the antimuscarinics and beta-3 agonists.
3. Review the salient features as well as changes in the updated AUA/SUFU guideline on OAB
4. Analyze the clinical (and theoretical) advantages and limitations of currently available agents
5. Discuss potential future pharmacological pathways and therapies for OAB.
ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas
CME Available: https://auau.auanet.org/node/41048
At the conclusion of this activity, participants will be able to:
1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB)
2. Review the principles of physiology and pharmacotherapy for currently available agents including the antimuscarinics and beta-3 agonists.
3. Review the salient features as well as changes in the updated AUA/SUFU guideline on OAB
4. Analyze the clinical (and theoretical) advantages and limitations of currently available agents
5. Discuss potential future pharmacological pathways and therapies for OAB.
ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas
Released:
Jun 12, 2024
Format:
Podcast episode
Titles in the series (49)
Case Based Discussion: Role of Genetic Testing and End of Life Care: Role of Genetic Testing in Advanced M1 CRPC & M1 … by AUAUniversity